Skip to content

King Pharmaceuticals KG Book value per share

Book value per share at other companies

Arch Capital Group logo
Arch Capital GroupACGL
$67.24+19.2%
SiriusPoint logo
SiriusPointSPNT
$18.92+10.8%
Skyward Specialty Insurance Group, Inc. logo
Skyward Specialty Insurance Group, Inc.SKWD
$26.95+32.1%
Verisk Analytics, Inc. logo
Verisk Analytics, Inc.VRSK
-$8.64-1,090%
W.R. Berkley logo
W.R. BerkleyWRB
$24.67+10.7%
Tiptree Inc. logo
Tiptree Inc.TIPT

Other financials

Income statement

See full
Revenue$10.2M+1,112%
Net income-$7.4M-1,786%
EPS (diluted)-$0.96-586%

Balance sheet

See full
Cash & equivalents$62.2M+1,724%
Total debt$176.7M
Total equity$121.4M+2,773%
Total assets$964.2M

Cash flow

See full
Operating cash flow-$15.1M-1,628%

Valuation

See full
Market cap$70.42M-71.3%
Enterprise value$184.93M-52.3%
P/E1.2×
P/S1.6×-27.7×

Profitability

See full
Net margin131.5%

Returns & leverage

See full
Return on equity90.8%
Debt / equity1.5×

Where this comes from

Calculated from King Pharmaceuticals’s reported figures.

Based on the most recent quarter.

The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is King Pharmaceuticals's book value per share?
King Pharmaceuticals (KG) reported book value per share of $15.66 in Q1 2026.
How has King Pharmaceuticals's book value per share changed year-over-year?
King Pharmaceuticals's book value per share increased by 919.1% year-over-year, from $1.54 to $15.66.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.